Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,720 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Guida A, Gili A, Mosillo C, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Fornarini G, Rebuzzi SE, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S. Guida A, et al. Among authors: lai e. Clin Genitourin Cancer. 2024 Sep 14;22(6):102225. doi: 10.1016/j.clgc.2024.102225. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39405768
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.
Babiker A, Warner S, Li X, Chishti EA, Saad E, Swihart BJ, Dekker JP, Walker M, Lawandi A, Kadri SS; NIH-Antimicrobial Resistance Outcomes Research Initiative. Babiker A, et al. Lancet Infect Dis. 2024 Oct 10:S1473-3099(24)00507-3. doi: 10.1016/S1473-3099(24)00507-3. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39396526
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors.
Madeddu C, Gramignano G, Lai E, Pinna G, Tanca L, Cherchi MC, Floris C, Farci D, Pretta A, Scartozzi M, Macciò A. Madeddu C, et al. Among authors: lai e. ESMO Open. 2024 Oct;9(10):103738. doi: 10.1016/j.esmoop.2024.103738. Epub 2024 Oct 10. ESMO Open. 2024. PMID: 39389003 Free article. Clinical Trial.
1,720 results